Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View

NVAX
Novavax Inc
stock NASDAQ

At Close
Jun 20, 2025 3:59:56 PM EDT
6.41USD+1.746%(+0.11)4,836,826
0.00Bid   0.00Ask   0.00Spread
Pre-market
Jun 20, 2025 9:27:30 AM EDT
6.33USD+0.476%(+0.03)40,579
After-hours
Jun 20, 2025 4:47:30 PM EDT
6.41USD0.000%(0.00)23,652
OverviewOption ChainMax PainOptionsPrice & VolumeSplitsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsMore
open chart   
open chart   
Market Cap
1.04B
CEO
Stanley Erck
Headquarters
Gaithersburg, Maryland, USA
Industry
Biotechnology
Last Split
May 10, 20191for20reverse
Related
BCRXACHNCLDXAZNGSKNVSPFEEBSAGENSRPTXLV
NVAX Stats
Avg. Vol. 10 Day
5,798,128
Avg. Vol. 30 Day
11,494,217
Employees
347
Market Cap
1,039,849,570
Shares Out.
161,970,338
On/Off Exchange
49%/51%
6 Month Beta
1.13
1 Year Beta
1.26
2 Year Beta
1.30
3 Year Beta
1.65
52 Week Low
5.01
52 Week High
17.81
SMA50
6.71
SMA200
8.68
1 Week
-8.68%
1 Month
-11.93%
3 Month
-15.53%
6 Month
-25.69%
1 Year
-54.14%
2 Year
-10.34%
5 Year
-90.27%
Profile
novavax, inc. is a clinical-stage vaccine company committed to delivering novel products to prevent a broad range of infectious diseases. our recombinant nanoparticles and matrix-m™ adjuvant technology are the foundation for groundbreaking innovation that improves global health through safe and effective vaccines. product pipeline our product pipeline targets a variety of infectious diseases with vaccine candidates currently in clinical development for respiratory syncytial virus ("rsv"​), seasonal influenza, pandemic influenza, and ebola virus ("ebov"​). we have additional preclinical-stage programs for a variety of infectious diseases. corporate overview novavax is headquartered in gaithersburg, maryland with additional facilities in rockville, maryland and uppsala, sweden. novavax is traded on the nasdaq stock market under the symbol nvax and employs over 300 individuals dedicated to developing novel vaccines to address infectious disease.

NVAX Stock Summary

Novavax Inc (NASDAQ:NVAX) stock price today is $6.41, and today's volume is 4,836,826. NVAX is up 1.746% today. The 30 day average volume is 11,494,217. NVAX market cap is 1.04B with 161,970,338 shares outstanding.



Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC